What is it about?
A retrospective review of all patients seen in two Community Paediatric clinics in NHS Fife between June 2016 and Jan 2017 was carried out. ADHD was diagnosed using validated SNAP-IV Questionnaire. 48/93 (52%) ADHD patients and 30/69 (43%) ASD patients presented with sleep difficulties (Table 1). 36/48 (75%) and 25/30 (83%) of the patients respectively were treated with Melatonin. •ADHD patients had significantly higher co-morbidities (3 vs 2) and clinics attended (average 2.3 vs 1.7). •There were no statistically significant differences between the mean age, socio-economic distribution, gender ratio, multi-professionals involved and “DNA” rates.
Featured Image
Why is it important?
Sleep problems affect up to 25% of typically developing school-aged children, and up to 80% of children with neurodevelopmental disorders. •They can adversely impact on children’s mental, social, developmental and daily living skills. •Sleep is a vital function of life and is a common presentation to healthcare professionals.
Perspectives
A significant proportion of children presenting with ASD and ADHD have sleep difficulties requiring treatment. The impact of disturbed and inadequate sleep in young children can be quite significant and include deleterious effects on cognitive development, mood regulation, attention, and behavior and overall quality of life, as well as negative effects on parents’ mental health.
Dr Michael O Ogundele
Mid Cheshire Hospitals NHS Foundation Trust Postgraduate Medical Centre
Read the Original
This page is a summary of: COMPARING THE PREVALENCE AND MANAGEMENT OF SLEEP DIFFICULTIES AMONG A COHORT OF CHILDREN WITH ASD AND ADHD IN A SCOTTISH LOCAL AUTHORITY, October 2018, Morressier,
DOI: 10.26226/morressier.5b5f433db56e9b005965b4df.
You can read the full text:
Contributors
The following have contributed to this page
